ClinicalTrials.gov
public full text
Public Domain
Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant
RATIONALE: Ondansetron may help lessen or prevent nausea and vomiting in patients undergoing stem cell transplant. PURPOSE: This phase II trial is studying how well ondansetron works in preventing nausea and vomiting in patients undergoing stem cell transplant.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter#683113
- Palonosetron Versus Ramosetron for the Prevention of Postoperative Nausea and Vomiting#845680
- Granisetron Versus Ondansetron: Comparative Effects on ECG, QTc#1432797
- Delayed Nausea and Vomiting in Patients With Colorectal Cancer Receiving Oxaliplatin#1362628
- Prediction of Moderate to Severe Delayed Chemotherapy‐Induced Nausea Using a Novel Algorithm Incorporating Individual Patient Factors.#30548
Record · ID 1445645
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive